FDA Nationwide Ergonomic Services
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA), Office of the Chief Scientist, Office of Occupational Safety and Health (OOSH), is soliciting quotations for Nationwide Ergonomic Services. This acquisition is a Total Small Business Set-Aside and anticipates awarding one (1) Time-and-Materials (T&M) Purchase Order. The goal is to provide a safe and healthy work environment for FDA employees through ergonomic consultative services. Quotations are due by February 13, 2026, at 2:00 PM ET.
Scope of Work
The contractor will provide comprehensive ergonomic services, including:
- Ergonomic education, presentations, and trainings.
- Consultation on the selection of furniture and equipment.
- Staffing for ergonomics assessments at FDA facilities nationwide.
- Conducting various types of assessments: Health, Reasonable Accommodations, Post-Injury, Assistive Technology, Virtual, and Follow-Up Assessments.
- Providing detailed written reports with findings and recommendations.
- In-service training on ergonomics and safety.
Contract Details
- Contract Type: Time-and-Materials (T&M) Purchase Order.
- Period of Performance: One (1) Base Year (anticipated March 30, 2026 - March 29, 2027), four (4) Option Years, and a 6-month Option to Extend Services (FAR 52.217-8).
- Set-Aside: Total Small Business Set-Aside.
- NAICS Code: 541690 - Other Scientific and Technical Consulting Services.
- Small Business Size Standard: $19 million.
Submission & Evaluation
- Quotations Due: February 13, 2026, at 2:00 PM ET.
- Questions Due: February 2, 2026, at 2:00 PM ET, using the provided RFQ Question Submittal Form (Attachment D).
- Submission Method: Electronic via email to Melinda Kim (Contract Specialist) and Nicholas Bisher (Contracting Officer).
- Evaluation Factors: Technical Understanding and Approach, Management Approach, Recent and Relevant Experience, Past Performance, and Price. Technical factors are considered more important than price.
Key Attachments & Notes
Offerors must complete and submit Attachment A_Pricing Worksheet.xlsx for labor and material pricing. Other critical attachments include Attachment B_Commitment to Protect Non-Public Information (NPI) Employee Agreement_Form FDA 3398.pdf and Attachment C_Past Performance Questionnaire.docx. The solicitation incorporates FAR provisions and clauses effective through FAC 2025-06 and requires compliance with Section 508 accessibility standards and specific security/privacy requirements.